VHL status regulates transforming growth factor-β signaling pathways in renal cell carcinoma
Open Access
- 27 March 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (23) , 16297-16310
Abstract
VHL status regulates transforming growth factor- signaling pathways in renal cell carcinoma VHL status regulates transforming growth factor-β signaling pathways in renal cell carcinomaKeywords
This publication has 40 references indexed in Scilit:
- Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal NeoplasmsBioMed Research International, 2015
- Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1–pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors?European Urology, 2015
- EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology, 2015
- Effects of TGF-β signaling in clear cell renal cell carcinoma cellsBiochemical and Biophysical Research Communications, 2013
- Systemic Therapy for Metastatic Non–Clear-Cell Renal Cell Carcinoma: Recent Progress and Future DirectionsHematology/Oncology Clinics of North America, 2011
- Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomyBMC Urology, 2010
- The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent mannerNature Cell Biology, 2008
- TGFβ in CancerCell, 2008
- Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancerEuropean Journal of Cancer, 2001
- The Heidelberg classification of renal cell tumoursThe Journal of Pathology, 1997